Flavonoid intake and coronary mortality in Finland: a cohort study

P Knekt, R Jarvinen, A Reunanen, J Maatela, P Knekt, R Jarvinen, A Reunanen, J Maatela

Abstract

Objective: To study the association between dietary intake of flavonoids and subsequent coronary mortality.

Design: A cohort study based on data collected at the Finnish mobile clinic health examination survey from 1967-72 and followed up until 1992.

Settings: 30 communities from different parts of Finland.

Subjects: 5133 Finnish men and women aged 30-69 years and free from heart disease at baseline.

Main outcome measure: Dietary intake of flavonoids, total mortality, and coronary mortality.

Results: In women a significant inverse gradient was observed between dietary intake of flavonoids and total and coronary mortality. The relative risks between highest and lowest quarters of flavonoid intake adjusted for age, smoking, serum cholesterol concentration, blood pressure, and body mass index were 0.69 (95% confidence interval 0.53 to 0.90) and 0.54 (0.33 to 0.87) for total and coronary mortality, respectively. The corresponding values for men were 0.76 (0.63 to 0.93) and 0.78 (0.56 to 1.08), respectively. Adjustment for intake of antioxidant vitamins and fatty acids weakened the associations for women; the relative risks for coronary heart disease were 0.73 (0.41 to 1.32) and 0.67 (0.44 to 1.00) in women and men, respectively. Intakes of onions and apples, the main dietary sources of flavonoids, presented similar associations. The relative risks for coronary mortality between highest and lowest quarters of apple intake were 0.57 (0.36 to 0.91) and 0.81 (0.61 to 1.09) for women and men, respectively. The corresponding values for onions were 0.50 (0.30 to 0.82) and 0.74 (0.53 to 1.02), respectively.

Conclusions: The results suggest that people with very low intakes of flavonoids have higher risks of coronary disease.

References

    1. Z Lebensm Unters Forsch. 1976;161(2):131-5
    1. Acta Med Scand Suppl. 1983;673:1-120
    1. Arch Intern Med. 1995 Feb 27;155(4):381-6
    1. Lancet. 1993 Oct 23;342(8878):1007-11
    1. Lancet. 1993 Feb 20;341(8843):454-7
    1. Biochem Pharmacol. 1987 Feb 1;36(3):317-22
    1. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2489-93
    1. Biochem Pharmacol. 1990 Jun 1;39(11):1743-50
    1. Free Radic Biol Med. 1990;9(1):19-21
    1. Am J Clin Nutr. 1990 Nov;52(5):903-8
    1. Biochem Pharmacol. 1993 Jan 7;45(1):67-75

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe